The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new chemotactic factor for human monocytes.
about
RANK-RANKL signalling in cancerRANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesHigh expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis.Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasisSubchondral pre-solidified chitosan/blood implants elicit reproducible early osteochondral wound-repair responses including neutrophil and stromal cell chemotaxis, bone resorption and repair, enhanced repair tissue integration and delayed matrix depTRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.Acute Osteoclast Activity following Subchondral Drilling Is Promoted by Chitosan and Associated with Improved Cartilage Repair Tissue Integration.Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages.The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathyMonocyte Proteomics Reveals Involvement of Phosphorylated HSP27 in the Pathogenesis of OsteoporosisCelecoxib: considerations regarding its potential disease-modifying properties in osteoarthritisFunctions of RANKL/RANK/OPG in bone modeling and remodeling.Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.Relaxin stimulates leukocyte adhesion and migration through a relaxin receptor LGR7-dependent mechanism.Runx2 Deletion in Smooth muscle Cells Inhibits Vascular Osteochondrogenesis and Calcification but not Atherosclerotic Lesion Formation."Omics" Signatures in Peripheral Monocytes from Women with Low BMD Condition.The importance of cell surface RANKL in rheumatoid arthritis.
P2860
Q26747442-1C8FD36B-2E4D-4116-B9C6-2914D8408F5CQ28570898-36C372BB-F77A-4794-8EC0-01E33C841C41Q33232238-E04ECFB7-5FAA-4590-B511-E8301D1D999DQ33877602-06A311B1-271F-4C7E-84E5-D6F7B2515E49Q34550026-256B02C3-0392-46DD-A3B3-04E8463916E2Q34989869-7B6D2299-D5A6-4DF4-AC68-6B0AA07B5761Q34991507-AE8BF179-A764-45B7-A6EA-592DB8F4A3F0Q34993353-933D0E60-2B47-49B0-9533-2059511203F0Q35123561-30F46F4D-5279-458E-BED9-38B29D92B0BEQ35630606-F57D4008-A0D1-430B-A389-FF8E8E224614Q35840709-D388E82E-6782-4748-A496-50B36FD287D3Q36700779-5145CD99-D6BA-46C1-85DE-7E642346D268Q36917940-F79FACD6-8D4A-4D06-9AD4-D2EAED201DBFQ37085639-829B495E-A0C5-46EA-A00F-0F1B7850C05CQ37350475-2671EDAB-0516-4705-9544-087849F8B881Q40348456-747566C4-213B-4F9B-9845-058A43D042E8Q42717904-1C6DED3E-FD5C-45FA-9CDF-3DC952F3245FQ55442346-F77ADCDE-6D58-4E68-AFD3-D80EB72B3688Q55510723-7AE1758E-8908-48FB-B451-642AF8F46821
P2860
The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new chemotactic factor for human monocytes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The receptor activator of nucl ...... ic factor for human monocytes.
@en
type
label
The receptor activator of nucl ...... ic factor for human monocytes.
@en
prefLabel
The receptor activator of nucl ...... ic factor for human monocytes.
@en
P2093
P50
P356
P1433
P1476
The receptor activator of nucl ...... ic factor for human monocytes.
@en
P2093
Bernard Rossi
Heidy Schmid-Antomarchi
Liana Euller-Ziegler
Roger Rezzonico
Véronique Breuil
P304
P356
10.1096/FJ.02-1188FJE
P407
P577
2003-07-18T00:00:00Z